Discover how advances in laboratory technologies are enabling clearer insights into patient health.

JUPITER, Fla - An upcoming segment of Advancements with Ted Danson will focus on developments in research, testing, and treatments for a wide range of cancers and chronic terminal illnesses.

With a look at Magnus Diagnostics Laboratories, Inc. (Magnus), audiences will learn how its testing practices and technologies equip healthcare providers with the latest in reporting and tracking capabilities that are currently available today. Viewers will see how Magnus provides tailored solutions to meet the needs of every healthcare provider, so they can respond faster, with clearer insights, into the health status of patients and clinical trials.

The show will explore how Magnus collects, tests, analyzes, and reports multiple sample types for review across a wide spectrum of industries. From routine primary care doctor level testing to high complexity molecular quantitation testing, spectators will discover how Magnus conducts specialized testing for rare diseases, disorders, and neuro-degenerative conditions like Alzheimer's and dementia.

"We look forward to sharing how we are ethically transforming cross sector pre-clinical research to clinical patient care," said Chris McNair, Co-Founder, Magnus Diagnostics.

In addition, the segment will highlight how Magnus strives to provide excellence across its specialties, which include drugs of abuse toxicology testing, research and development testing, primary care patient testing, and therapeutic drug level monitoring contracts.

"We look forward to sharing how developments in science and technology are supporting the search for new treatments," said Richard Lubin, senior producer for the Advancements series.